OLUMUYIWA GAY: Open Payments
NPI 1477708311 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 51 payments from 10 companies in 2025. Trend: 2023 $595 · 2024 $716 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $181 |
| E.R. Squibb & Sons, L.L.C. | 15 | $180 |
| Alkermes, Inc. | 8 | $164 |
| Axsome Therapeutics, Inc. | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 5 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Lundbeck LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, COBENFY, ARISTADA, Auvelity, AUSTEDO XR, REXULTI, INVEGA, Jornay PM.
Industry payments across NY — which companies pay providers there.
